This study is testing a device called DermaSensor to see how well it can identify skin lesions that might be melanoma. The DermaSensor device uses light to compare suspicious spots on your skin to known benign (non-cancerous) or malignant (cancerous) lesions. We are looking for men and women aged 40 and older who have a skin lesion that their doctor thinks might be melanoma. The main goal is to see how accurate the DermaSensor device is at detecting melanoma. The study is currently unclear on its recruitment status and plans to enroll 396 participants.

Study design

This is an interventional study that plans to enroll 396 participants. It is evaluating a device rather than a drug.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The device's sensitivity will be measured at 39 months, suggesting a follow-up period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.